Does EVEROLIMUS Cause Breast cancer? 607 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 607 reports of Breast cancer have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 1.5% of all adverse event reports for EVEROLIMUS.
607
Reports of Breast cancer with EVEROLIMUS
1.5%
of all EVEROLIMUS reports
150
Deaths
127
Hospitalizations
How Dangerous Is Breast cancer From EVEROLIMUS?
Of the 607 reports, 150 (24.7%) resulted in death, 127 (20.9%) required hospitalization, and 11 (1.8%) were considered life-threatening.
Is Breast cancer Listed in the Official Label?
Yes, Breast cancer is listed as a known adverse reaction in the official FDA drug label for EVEROLIMUS.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Breast cancer?
RANITIDINE (45,666)
LETROZOLE (1,393)
ETANERCEPT (1,303)
METHOTREXATE (936)
ADALIMUMAB (894)
INFLIXIMAB (789)
RIBOCICLIB (788)
FULVESTRANT (684)
DENOSUMAB (671)
ABATACEPT (617)
Which EVEROLIMUS Alternatives Have Lower Breast cancer Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE